Tegretol-xr and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Tegretol-xr (carbamazepine), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Depakote, and have Attention deficit hyperactivity disorder.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Tegretol-xr. It is created by eHealthMe based on reports of 1,294 people who have side effects when taking Tegretol-xr from the FDA, and is updated regularly.

What is Tegretol-xr?

Tegretol-xr has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 1,666 Tegretol-xr users. Check the latest studies of Tegretol-xr.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,754 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Jul, 09, 2026

1,294 people reported to have side effects when taking Tegretol-xr.
Among them, 20 people (1.55%) have Hypersensitivity.

Could Tegretol-xr cause Hypersensitivity?

Among these 20 people:

How long have people been on Tegretol-xr when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Tegretol-xr? *

female: 45 %
male: 55 %

What is the age of people who have Hypersensitivity when taking Tegretol-xr? *

What are other drugs people take besides Tegretol-xr? *

What are other side effects people have besides Hypersensitivity? *

Fever: 6 people, 30.00%
Rash Erythematous (redness of the skin): 4 people, 20.00%
White Blood Cell Count Increased: 3 people, 15.00%
Rashes (redness): 3 people, 15.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%
Weakness: 3 people, 15.00%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 3 people, 15.00%
Mononucleosis Syndrome (an infection that produces flu-like symptoms, and usually goes away on its own in a few weeks): 3 people, 15.00%
Swallowing Difficulty: 3 people, 15.00%
C-Reactive Protein Increased: 3 people, 15.00%

What are the existing conditions these people have? *

Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 1 person, 5.00%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 1 person, 5.00%
Gastritis (inflammation of stomach): 1 person, 5.00%
Depression: 1 person, 5.00%
Birth Control: 1 person, 5.00%
Autoimmune Hepatitis: 1 person, 5.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tegretol-xr and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tegretol-xr:

Tegretol-xr (1,666 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Tegretol-xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,754 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

Related publications that referenced our studies

Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Tegretol-xr) and Tegretol-xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.